What is the difference between an autologous and a homologous blood transfusion?

There are two forms of blood doping: autologous and homologous. Autologous blood doping is the transfusion of one’s own blood, which has been stored (refrigerated or frozen) until needed. Homologous blood doping is the transfusion of blood that has been taken from another person with the same blood type.

What are methods of autologous transfusion?

Autologous transfusion can be performed in three ways: (1) preoperative blood collection, storage, and retransfusion during surgery; (2) immediate preoperative phlebotomy with subsequent artificial hemodilution and later return of the phlebotomized blood; and (3) intraoperative blood salvage and retransfusion.

Is autologous blood transfusion safe?

Neverless, autologous transfusion does not protect from all risks, it still remains the safest type of blood transfusion and is important in the strategy of blood conservation.

What is autologous blood and why is it used?

Autologous donor programs allow a patient to donate blood for their own use. Autologous transfusion indicates that the blood donor and transfusion recipient are identical. This is the safest possible transfusion a patient can receive and is an excellent option for patients facing elective surgery.

What is difference between autologous and homologous?

Autologous blood transfusion is the collection and re-infusion of the patient’s own blood or blood components. Homologous, or more correctly allogenic, blood transfusions involves someone collecting and infusing the blood of a compatible donor into him/herself.

What is importance of autologous transfusion?

Autologous blood transfusion may reduce the transfusion-associated mortality by 70%. Another advantage of preoperative autologous blood donation is the increase in erythropoiesis. Immunologic and viral infectious complications have not been reported with transfusion of autologous blood.

How much does autologous blood cost?

The total cost of acquisition, processing, and transfusion of 1 U of preoperatively donated autologous blood was $97.83. The total cost of a 2-U transfusion of autologous whole blood donated in the operating room during acute normovolemic hemodilution was $83.10.

What are the benefits of autologous blood transfusion?

Who is the best candidate for autologous donation?

Who is the best candidate for a predeposit autologous donation? The 45-year-old man with alloanti-k is the best candidate for predeposit autologous donation because compatible blood will be hard to find if he needs blood after surgery.

Is blood compatible with lactated Ringer’s?

Background: Blood bank recommendations specify that Ringer’s lactate solution (LR) should be avoided while transfusing blood. However, there are few studies either evaluating or quantifying increased coagulation during rapid infusion of LR and blood.

What’s the difference between autologous and homologous blood transfusions?

Autologous blood transfusion is the collection and re-infusion of the patient’s own blood or blood components. Homologous, or more correctly allogenic, blood transfusions involves someone collecting and infusing the blood of a compatible donor into him/herself.

Is it safe to use autologous blood transfusion?

Although PAD may reduce exposure to donor blood, it does not reduce overall exposure to transfusion procedures or protect against wrong blood into patient episodes due to identification errors at collection from the blood bank or at the bedside. Indeed, the availability of autologous blood may increase the risk of unnecessary transfusion.

When to use autologous blood transfusion in ICS?

Commercially available, largely automated devices are available for ICS and are now widely used in hospitals for both elective and emergency surgery with significant blood loss and in the management of major traumatic or obstetric haemorrhage.

Can a Jehovah Witness have an autologous blood transfusion?

Indeed, the availability of autologous blood may increase the risk of unnecessary transfusion. Most Jehovah’s Witnesses will decline PAD ( see Chapter 12 ). Clinical trials of PAD are mainly small and of low quality and do not provide strong evidence that the risks outweigh the benefits.